The global type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding growth over the forecast period. This is majorly due to the significant increase in type 1 diabetes (T1D) prevalence followed by rising uptake of novel formulations of insulin analogs and auxiliary therapies. As per International Diabetes Federation (IDF), in 2015 around 542,000 children aged under 14 years were affected by T1D worldwide and is expected to increase in the future thereby increasing the uptake of insulin analogs.
$ 0.00
Download Now